The picturesque palm-fringed beaches of the Caribbean and the tropical islands of Jamaica are the stuff of shining travel brochures. Still, the barefoot holidaymakers who travel the Jamaican retreats in winter look a very different kind of journey. They are here to get acquainted with the psychedelic psilocybin fungus, and it is often people like them who are willing to seek help with the mysterious fungus, if at all. The first established p-Silo, or “Silo,” was founded in North America in 2015 and has seen an increasing interest in its supposed psychological benefits in the years since.
Jessica, a 41-year-old manager in Atlanta who flew to Jamaica in November 2019 for the MycoMeditation retreat, said: ‘I’ve never done psychedelics, and I’m a bit skeptical, but she’s a pretty character.
But Young knows about psychedelics, having read books that are about changing your mind, like Dr. Michael Pollan’s book “The Psychedelic Mind.”
Psilocybin in 2021
Pollan examines what recent psychedelic research has shown the effects of psilocybin, a crystallized poison, and its effects on the brain. Young had just turned 40 when she read the book. She was intrigued by the fact that it seemed to offer her personal growth. Such courses alternated between Polan’s eyebrows and Young’s eyes: “I’m in love with this book. The U.S. Food and Drug Administration (FDA) classifies psilocybin fungi as a “category 1” drug, according to its website.
Psilocybin is not illegal here, but there are few places in the world where you can actually use the substance, “says Justin Townsend, CEO, and head of MycoMeditations. In recent months, decriminalization efforts have torn a rift in U.S. drug laws. D.C. voters recently approved an initiative to decriminalize the use of psilocin mushrooms. While Oregon residents supported legal to use in therapeutic settings. Young people who have been convicted of the crime would likely have to look abroad for legal access to the drug, Pollan said.
For months, researcher Robin Carhart-Harris’s inbox has been filled with requests to attend a psilocybin retreat for young people with mental health problems. They are desperate, and other treatments may not work, but they desperately need some kind of treatment, “she says, filling her inbox every month.
Research on Magic Mushrooms
Later this year, Johns Hopkins will open the Center for Psychedelic Consciousness Research. When it opened in 2019, it will be the first official site in the world to focus exclusively on psychedelic research. According to Carhart-Harris, more than a third of those who participate in clinical trials use psilocybin because they suffer from depression, anxiety, post-traumatic stress disorder, or other mental health problems.
A few days are typical, but after that, “it’s really sad and there’s nothing you can do about it,” she says, according to Carhart-Harris.
U.S. News and World Report speculated last year that psilocybin could supplant cannabis as a hot investment. According to a report in the New York Times, U.S. News & World speculated last year that “psilocin” could displace “cannabis as a” hot investment “in the US.
Magic Mushroom Retreats
According to a New York Times report, the new research center was closed because of increased interest in tightly controlled studies.
The retreats have revealed a remarkable range of effects on mental health, from depression to anxiety to depression – such as symptoms.
Carhart-Harris is optimistic about psychedelic applications outside the lab. Her research has convinced her that psychedelics can make a profound difference. Compared to other drugs, even alcohol, psilocybin is remarkably safe. It is not addictive, its toxicity is very low, it is not used in the same way as other psychoactive substances such as LSD ecstasy. But it is much more effective. Others are more traditional, in the tradition of shamanism, such as shamanic rituals and healing rituals.